共 79 条
[1]
Delaleu N(2005)Sjogren’s syndrome Eur J Oral Sci 113 101-13
[2]
Jonsson R(2012)Sjogren’s syndrome, the old and the new Best Practice Res Clin Rheumatol 26 105-17
[3]
Koller MM(2013)ABATACEPT treatment reduces disease activity in early primary Sjogren’s syndrome (Phase Ii Open Label ASAP Study) Ann Rheum Dis 72 89-8
[4]
Peri Y(2014)Comparison of the American-European Consensus Group Sjogren’s syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort Ann Rheum Dis 73 31-5
[5]
Agmon-Levin N(2012)Novel autoantibodies in Sjogren’s syndrome Clin Immunol 145 251-4
[6]
Theodor E(2009)An early view of the international Sjogren’s syndrome registry Arthritis Rheum 61 711-12
[7]
Shoenfeld Y(2009)IL-14alpha, the Nexus for primary Sjogren’s disease in mice and humans Clin Immunol 130 304-13
[8]
Meiners P(2013)Different stages of primary Sjogren’s syndrome involving lymphotoxin and type 1 IFN J Immunol 191 608-63
[9]
Vissink A(2011)Aspects of innate immunity in Sjogren’s syndrome Arthritis Res Ther 13 218-5
[10]
Kroese F(2010)A role for lymphotoxin in primary Sjogren’s disease J Immunol 185 6355-33